Author

Wolfgang Mikulits

Comprehensive Cancer Center ViennaORCID 0000-0003-4612-7106Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

Aleksandr BykoviD· 1 shared Ali El‐Ayoubi· 1 shared Arsen ArakelyaniD· 1 shared Barbara Sax· 1 shared Branka Radic-SarikasiD· 1 shared Danijela Kurija· 1 shared Florian HalbritteriD· 1 shared Gerhard Weber· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aleksandr BykovORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCell ReportsPeer-reviewedMar 1, 2025

YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1 mediated reprogramming of bone mesenchymal stem cells

Rahil Noorizadeh, Barbara Sax, Tahereh Javaheri…·Heinrich Kovar

The paper shows that IGF-1 reprograms bone mesenchymal stem cells in EWS::FLI1-mutant mice, leading to tumor formation, with Yap1 playing a central role, and suggests combined IGF-1R and YAP/TEAD inhibition as a potential treatment.

11 citations

mouseexperimental assay

𝕏 PostBluesky

Molecular BiologyMolecular OncologyPeer-reviewedDec 20, 2023

Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system

Ali El‐Ayoubi, Arsen Arakelyan, Moritz Klawitter…·Ulrike Naumann

The paper develops a non-tumorigenic cell line, LX-2, for intranasal delivery of oncolytic viruses to the brain, showing improved resistance to viral replication and safety in mice.

3 citations

mouseexperimental assay

𝕏 PostBluesky